01.22.25 -- Autonomous Decision-Making: Are We Ready for Agentic AI

We're ready to help usher your next drug into market! 2025's first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry's best and give you complimentary VIP access to the resources available to support your success. Learn more and register to save your seat!

By fostering a proactive, technology-driven environment, pharma manufacturers can ensure swift, accurate tracking of adverse events while advancing patient safety and meeting compliance standards.

To ensure the safety of personnel throughout the production of HPAPIs, manufacturers must effectively utilize containment and well-designed equipment.

Explore our series on key industry advocacy groups to learn how organizations like California Life Sciences (CLS) are driving innovation, fostering growth, and improving patient access in healthcare.

As molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology to facilitate the integration of complex synthetic methods into API production.

Gain insights on transitioning from batch to continuous flow processes, the benefits of continuous flow chemistry, and ensuring regulatory compliance with Quality by Design (QbD) principles.

3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Consider the possibilities of forming stable suspension in printing ink from nanoformed materials.

Combination therapies delivered directly to the lung by dry powder inhalants are an effective means of reducing patient burden. Here, we illustrate its potential for improving care for critically ill patients.

Save the date for February 6th! Explore key drivers and delivery options for injectable and oral peptides. Learn strategies for transitioning from IV to subcutaneous delivery, phasing CMC investment, and minimizing risks. Hear insights from 14 oral peptide programs, PBPK modeling, and rapid pharmacokinetic prototyping to optimize development and meet target product profiles. Click here to learn more.

The Flex Lab Isolator (FLI) is a versatile solution designed for aseptic laboratory applications, clinical studies, and small-batch production.

Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.

The growing need for convenient and tamper-free packaging has proliferated the demand for blister packaging. Learn about contract blister packaging services that can produce several different forms.